Theravance Biopharma, Inc. Contracts & Agreements

85 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Theravance Biopharma, Inc. Executive Severance Plan and Summary Plan Description
Theravance Biopharma, Inc.
Pharmaceuticals
2025
Employment Contract with Aine Miller
Theravance Biopharma, Inc.
Pharmaceuticals
2024
Form of Restricted Share Purchase Agreement under the Amended and Restated 2013 Equity Incentive Plan
Theravance Biopharma, Inc.
Pharmaceuticals
2024
Separation and Release of Claims by and between Richard Graham and Theravance Biopharma US, Inc
Theravance Biopharma, Inc.
Pharmaceuticals
CA
2024
Offer Letter with Rhonda Farnum dated July 9, 1018
Theravance Biopharma, Inc.
Pharmaceuticals
2024
Cooperation Agreement, dated as of December 21, 2023, by and among Theravance Biopharma, Inc., a Cayman Islands exempted company, Irenic Capital Management LP, a Delaware limited...
Management Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2023
Offer Letter with Brett Grimaud dated May 12, 2014
Theravance Biopharma, Inc.
Pharmaceuticals
2023
Offer Letter with Aziz Sawaf dated June 16, 2014
Theravance Biopharma, Inc.
Pharmaceuticals
2023
Form of Theravance Biopharma, Inc. 2013 Equity Incentive Plan Notice of Restricted Share Unit Award and Restricted Share Unit Agreement
Bonus & Incentive Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2023
Amended and Restated 2013 Equity Incentive Plan of Theravance Biopharma, Inc
Bonus & Incentive Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2023
Settlement Agreement and Release of Claims by and between Andrew Hindman and Theravance Biopharma US, Inc., dated January 10, 2023
Settlement Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
CA
2023
Audited financial statements of Theravance Respiratory Company, LLC for the year ended December 31, 2021
Theravance Biopharma, Inc.
Pharmaceuticals
2023
First Amendment to the Theravance Biopharma, Inc. Change in Control Severance Plan
Change of Control Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
CA
2022
Equity Purchase and Funding Agreement, dated as of July 13, 2022, by and between Theravance Biopharma, Inc. and Royalty Pharma Investments 2019 ICAV
Purchase Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2022
Master Consent, dated as of July 13, 2022, by and among Glaxo Group Limited, Theravance Biopharma, Inc. and Royalty Pharma Investments 2019 ICAV
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2022
Release Agreement, dated as of July 13, 2022, by and among Innoviva, Inc., Innoviva TRC Holdings LLC, Royalty Pharma Investments 2019 ICAV, Theravance Respiratory Company, LLC,...
Release Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2022
Form of Separation Agreement and Release of Claims between California-based departing executives and Theravance Biopharma US, Inc
Separation Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
CA
2022
Consulting Agreement between Vijay Sabesan and Theravance Biopharma US, Inc., dated November 30, 2021
Consulting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
CA
2022
Settlement Agreement by and between Ann Brady and Theravance Biopharma Ireland Limited, dated November 2, 2021
Settlement Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2022
Audited financial statements of Theravance Respiratory Company, LLC for the year ended December 31, 2021
Theravance Biopharma, Inc.
Pharmaceuticals
2022
Underwriting Agreement among Theravance Biopharma, SVB Leerink LLC, Evercore Group L.L.C. and Credit Suisse Securities (USA) LLC, as representatives of the several underwriters,...
Underwriting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2021
Development and Commercialization Agreement by and between Theravance Biopharma R&D, Inc. and Mylan Ireland Limited, dated January 30, 2015
Development Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2021
License and Collaboration Agreement by and between Theravance Biopharma Ireland Limited and Janssen Biotech, Inc. dated as of February 5, 2018
Collaboration Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
PA
2021
Offer Letter with Richard Graham August 12, 2015
Theravance Biopharma, Inc.
Pharmaceuticals
2020
Cooperation Agreement among Theravance Biopharma, Inc., GSK Finance (No.3) plc and GlaxoSmithKline plc dated June 22, 2020
Cooperation Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2020
Waiver and Assignment of Registration Rights and Voting Agreement among GSK Finance (No.3) plc, Glaxo Group Limited and Theravance Biopharma, Inc. dated as of June 22, 2020
Registration Rights Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2020
Registration Rights Agreement among Theravance Biopharma, Inc., GSK Finance (No.3) plc and GlaxoSmithKline plc dated June 22, 2020
Registration Rights Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2020
Brett K. Haumann Theravance Biopharma UK Ltd. Contract of Employment
Employment Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2020
First Amendment of Registration Rights Agreement with Glaxo Group Limited
Registration Rights Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2020
Brett K. Haumann Transfer to Theravance Biopharma UK Ltd. Memo
Theravance Biopharma, Inc.
Pharmaceuticals
2020
License Agreement by and between Theravance Biopharma Ireland Limited and Pfizer Inc. dated December 21, 2019
License Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2020
Form of Note Purchase Agreement, dated February 21, 2020 by and among Theravance Biopharma R&D, Inc., Triple Royalty Sub II LLC, and the Purchasers
Note Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2020
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Theravance Biopharma, Inc.
Pharmaceuticals
2020
Underwriting Agreement among Theravance Biopharma, Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC, as representatives of the several underwriters,...
Underwriting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2020
Offer Letter with Andrew Hindman dated May 30, 2019
Theravance Biopharma, Inc.
Pharmaceuticals
2019
Amendment No. 1 to the Development and Commercialization Agreement by and between Theravance Biopharma Ireland Limited and Mylan Ireland Limited, dated June 12, 2019
Development Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2019
Agreement and General Release between Theravance Biopharma US, Inc. and Shehnaaz Suliman, dated March 1, 2019
Release Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
CA
2019
Form of Note Purchase Agreement, dated November 30, 2018
Note Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2018
Asset Purchase Agreement, dated as of November 1, 2018, by and among Cumberland Pharmaceuticals Inc. on the one hand, and Theravance Biopharma Ireland Limited and Theravance...
Purchase Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2018
Memorandum to Brett K. Haumann regarding Transfer to Theravance Biopharma US, Inc., executed April 5, 2018
Theravance Biopharma, Inc.
Pharmaceuticals
CA
2018
Amendments to Lease for 901 Gateway Boulevard between Theravance Biopharma US, Inc. and ARE-901/951 Gateway Boulevard, LLC
Lease Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2018
Amendments to Lease for 951 Gateway Boulevard between Theravance Biopharma US, Inc. and ARE-901/951 Gateway Boulevard, LLC
Lease Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2018
Amendment and Termination of Rights Agreement, dated as of May 1, 2018, between the Company and Computershare Inc
Termination Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2018
Form of Notice of Performance Restricted Share Unit Award and Restricted Share Unit Agreement under the Companys Performance Incentive Plan
Bonus & Incentive Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2017
Form of Notice of Option Grant and Option Agreement under the Companys Performance Incentive Plan
Bonus & Incentive Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2017
Offer Letter with Shehnaaz Suliman dated May 31, 2017
Theravance Biopharma, Inc.
Pharmaceuticals
2017
FOURTH AMENDMENT TO TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT between PFIZER, INC. and THERAVANCE BIOPHARMA IRELAND LIMITED
Supply Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
FIRST AMENDMENT TO TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT BETWEEN HOSPIRA WORLDWIDE, INC. and THERAVANCE, INC.
Supply Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
SECOND AMENDMENT TO TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT between BETWEEN HOSPIRA WORLDWIDE, INC. and THERAVANCE BIOPHARMA ANTIBIOTICS, INC.
Supply Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
THIRD AMENDMENT TO TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT between HOSPIRA WORLDWIDE, INC. and THERAVANCE BIOPHARMA IRELAND LIMITED
Supply Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
THERAVANCE BIOPHARMA, INC. (a Cayman Islands exempted company) 3,850,000 Ordinary Shares UNDERWRITING AGREEMENT
Underwriting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
THERAVANCE BIOPHARMA, INC. (a Cayman Islands exempted company) $200,000,000 3.250% Convertible Senior Notes due 2023 UNDERWRITING AGREEMENT
Underwriting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
THERAVANCE BIOPHARMA, INC. as Issuer and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee Trustee Indenture Dated as of November 2, 2016
Indenture Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
THERAVANCE BIOPHARMA, INC. 3.25% CONVERTIBLE SENIOR NOTES DUE 2023 FIRST SUPPLEMENTAL INDENTURE DATED AS OF NOVEMBER 2, 2016 WELLS FARGO BANK, NATIONAL ASSOCIATION AS TRUSTEE
Indenture Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
THERAVANCE BIOPHARMA, INC. 3.25% CONVERTIBLE SENIOR NOTES DUE 2023 FIRST SUPPLEMENTAL INDENTURE DATED AS OF NOVEMBER 2, 2016 WELLS FARGO BANK, NATIONAL ASSOCIATION AS TRUSTEE
Indenture Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
LICENSE AND COLLABORATION AGREEMENT BY AND BETWEEN THERAVANCE BIOPHARMA IRELAND LIMITED AND MILLENNIUM PHARMACEUTICALS, INC. DATED JUNE 8, 2016
Collaboration Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
AMENDMENT NO. 1 TO THE LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENT
License Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
THERAVANCE BIOPHARMA, INC. ORDINARY SHARE PURCHASE AGREEMENT March 14, 2016
Share Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2016
THERAVANCE BIOPHARMA, INC. PERFORMANCE INCENTIVE PLAN PURPOSE
Bonus & Incentive Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
THERAVANCE BIOPHARMA, INC. (a Cayman Islands exempted company) 4,765,000 Ordinary Shares UNDERWRITING AGREEMENT
Underwriting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
THERAVANCE BIOPHARMA, INC. 2013 EQUITY INCENTIVE PLAN NOTICE OF OPTION GRANT
Bonus & Incentive Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
ACKNOWLEDGEMENT
Theravance Biopharma, Inc.
Pharmaceuticals
2016
Theravance Biopharma, Inc. 2013 Equity Incentive Plan (the Plan) Irish Addendum
Bonus & Incentive Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan (the Plan) UK Addendum
Share Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
Theravance Biopharma, Inc. 2014 New Employee Equity Incentive Plan (the Plan) Irish Addendum
Bonus & Incentive Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
FIRST AMENDMENT TO RIGHTS AGREEMENT
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2015
THERAVANCE BIOPHARMA, INC. ORDINARY SHARE PURCHASE AGREEMENT October 26, 2015
Share Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2015
THERAVANCE BIOPHARMA, INC. ORDINARY SHARE PURCHASE AGREEMENT October 7, 2015
Share Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2015
DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
Development Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2015
THERAVANCE BIOPHARMA, INC. ORDINARY SHARE PURCHASE AGREEMENT January 30, 2015
Share Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
PA
2015
CONSULTING AGREEMENT
Consulting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
CA
2015
EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off
Theravance Biopharma, Inc.
Pharmaceuticals
2014
License Agreement
License Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2014
Theravance Biopharma, Inc. 2013 Equity Incentive Plan (the Plan) UK ADDENDUM
Bonus & Incentive Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2014
EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off
Theravance Biopharma, Inc.
Pharmaceuticals
2014
EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off
Theravance Biopharma, Inc.
Pharmaceuticals
2014
EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off
Theravance Biopharma, Inc.
Pharmaceuticals
2014
EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off
Theravance Biopharma, Inc.
Pharmaceuticals
2014
CONSENT TO ASSIGNMENT
Assignment Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2014
CONSENT TO ASSIGNMENT
Assignment Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2014
THERAVANCE RESPIRATORY COMPANY, LLC LIMITED LIABILITY COMPANY AGREEMENT May 31, 2014
Limited Liability Company Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2014
EMPLOYEE MATTERS AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 1, 2014
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2014
TAX MATTERS AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 2, 2014
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2014
TRANSITION SERVICES AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 2, 2014
Transition Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2014
SEPARATION AND DISTRIBUTION AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 1, 2014
Separation Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2014